ArticleJournal of experimental & clinical cancer research : CR2017

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.

Bo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.